Wall Street Journal reports that Peggy Hamburg and Joshua Sharfstein are expected to become commissioner and deputy commissioner, respectively, of the US Food and Drug Administration. Hamburg was a health commissioner in New York City, and Sharfstein is the health chief in Baltimore. "The White House wants to position the FDA commissioner as someone who will lead the agency back to its core mission of public health, and the focus on Dr. Hamburg and Dr. Sharfstein fits that message, said people close to the situation," the article says.